ASTRO 2021: Validation of a 22-Gene Genomic Classifier in the NRG Oncology/RTOG 9202, 9413, and 9902 Phase III Randomized Trials: A Biopsy-Based Individual Patient Meta-Analysis in High Risk Prostate Cancer

ASTRO 2021 biomarkers and salvage radiotherapy prostate cancer, the validation of a 22-gene genomic classifier in the NRG Oncology/RTOG 9202 9413 and 9902 phase III randomized trials, decipher genomic classifier prostate cancer, decipher prostate cancer test

Read the full article here

Related Articles